Syneron Medical Ltd (ELOS) Tops Q1 Estimates

Syneron Medical Ltd (NASDAQ: ELOS) reported Q1 EPS of ($0.07), $0.08 better than the analyst estimate of ($0.15). For Q1, Non-GAAP net income per share attributable to Syneron shareholders operations before non-controlling interest came out to $0.02 profit.

Revenue for the quarter came in at $62.66 million versus the consensus estimate of $55.91 million.

For earnings history and earnings-related data on Syneron Medical Ltd (ELOS) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
• CoStar Group acquires Zonda for $800M, adding new home data
• Investing.com’s stocks of the week